Mulder T P, Verspaget H W, Janssens A R, de Bruin P A, Griffioen G, Lamers C B
Department of Gastroenterology and Hepatology, University Hospital Leiden, The Netherlands.
Free Radic Biol Med. 1990;9(6):501-6. doi: 10.1016/0891-5849(90)90128-6.
Cu/Zn-containing proteins have recently become of interest with regard to their relation with malignant disorders. Cu Zn-superoxide dismutase (Cu/Zn-SOD) was found increased in chemically induced tumors of the large bowel whereas metallothionein (MT), containing Zn and some Cu, was shown important for the response of tumors to chemotherapy. In the present study, we evaluated the Cu/Zn-SOD and MT content of normal human colonic mucosa and colorectal carcinomas, obtained from 20 resection specimens, and of 47 adenomatous polyps. The Cu/Zn-SOD content of polyps and carcinomas was significantly (p less than 0.01) elevated when compared to normal mucosa. In the adenomatous polyps the Cu/Zn-SOD content increased significantly with increasing grade of epithelial cell dysplasia, diameter, and presence of a villous component. In the carcinomas no relation was noticed between the Cu/Zn-SOD content and the Dukes' stage or the grade of differentiation. The MT content was significantly decreased in both adenomatous polyps and carcinomas when compared to that in normal mucosa. The MT content was not related to the grade of epithelial cell dysplasia of the polyps, and to the Dukes' stage or the differentiation of the carcinomas. In conclusion, neoplasia of the colorectum is accompanied by an increase in Cu/Zn-SOD and a decrease in MT. These findings support the association between changes in Cu/Zn proteins and malignancy.
含铜/锌蛋白因其与恶性疾病的关系,近来受到关注。在化学诱导的大肠肿瘤中,发现铜锌超氧化物歧化酶(Cu/Zn-SOD)含量增加,而含锌和一些铜的金属硫蛋白(MT),对肿瘤对化疗的反应很重要。在本研究中,我们评估了从20份切除标本中获取的正常人类结肠黏膜和结直肠癌,以及47枚腺瘤性息肉中的Cu/Zn-SOD和MT含量。与正常黏膜相比,息肉和癌组织中的Cu/Zn-SOD含量显著升高(p<0.01)。在腺瘤性息肉中,Cu/Zn-SOD含量随着上皮细胞发育异常程度、直径以及绒毛成分的出现而显著增加。在癌组织中,未发现Cu/Zn-SOD含量与Dukes分期或分化程度之间存在关联。与正常黏膜相比,腺瘤性息肉和癌组织中的MT含量均显著降低。MT含量与息肉上皮细胞发育异常程度、癌组织的Dukes分期或分化无关。总之,结直肠癌形成伴随着Cu/Zn-SOD增加和MT减少。这些发现支持了铜/锌蛋白变化与恶性肿瘤之间的关联。